No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome

American Journal of Psychiatry

Volumn 163, Issue 3, 2006, Pages 537-539

  Glaser, Bronwyn ^a   Debbane, Martin ^a   Hinard, Christine ^a   Morris, Michael A ^a   Dahoun, Sophie P ^a   Antonarakis, Stylianos E ^a   Eliez, Stephan ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Service Medico Pedagogique   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN FUNCTION; CHILD; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL ARTICLE; COGNITION; FEMALE; HEMIZYGOSITY; HUMAN; INTELLIGENCE QUOTIENT; MALE; MENTAL PERFORMANCE; PRIORITY JOURNAL; VERBAL MEMORY; VISUAL MEMORY; COGNITIVE DEFECT; COMPARATIVE STUDY; DIGEORGE SYNDROME; ENZYMOLOGY; FRONTAL LOBE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; CHILD; COGNITION DISORDERS; DIGEORGE SYNDROME; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHIONINE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; VALINE;

EID: 33645922451     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.3.537     Document Type: Article

References (14)

1. Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56:940-945
2. Wang PP, Woodin MF, Kreps-Falk R, Moss EM: Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2). Dev Med Child Neurol 2000; 42:422-427
3. Gothelf D, Presburger G, Levy D, Nahmani A, Burg M, Berant M, Blieden LC, Finkelstein Y, Frisch A, Apter A, Weizman A: Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Am J Med Genet B Neuropsychiatr Genet 2004; 126:116-121
4. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM: Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 1998; 3:346-349
5. Weinshilboum RM, Raymond FA: Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 1977; 29:125-135.
6. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I: Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 1997; 7:65-71
7. Herken H, Erdal ME: Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatr Genet 2001; 11:105-109
8. Tunbridge E, Burnet PW, Sodhi MS, Harrison PJ: Catechol-O- methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 2004; 51:112-118
9. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF: Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardiofacial syndrome. Am J Med Genet 1996; 67:468-472
10. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ: Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 2004; 161:1700-1702
11. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 1995; 92:7612-7616
12. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatrie disorders. Pharmacogenetics 1996; 6:243-250
13. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR: Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003; 60:889-896
14. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D: A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159:652-654